The store will not work correctly when cookies are disabled.
(S)-N-(2-((S)-2-carbamoylpyrrolidin-1-yl)-2-oxoethyl)-5-oxopyrrolidine-2-carboxamide
ID: ALA3940595
Cas Number: 42294-01-9
PubChem CID: 71363192
Max Phase: Preclinical
Molecular Formula: C12H18N4O4
Molecular Weight: 282.30
Molecule Type: Protein
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1
Standard InChI: InChI=1S/C12H18N4O4/c13-11(19)8-2-1-5-16(8)10(18)6-14-12(20)7-3-4-9(17)15-7/h7-8H,1-6H2,(H2,13,19)(H,14,20)(H,15,17)/t7-,8-/m0/s1
Standard InChI Key: XKFFWWWMHGXEPW-YUMQZZPRSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
20.0490 -9.5364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0670 -9.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8210 -10.1373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6324 -8.7197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8414 -7.4943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0416 -10.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3427 -9.9448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9262 -9.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6744 -9.4360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6324 -9.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6332 -10.2235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8403 -10.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5007 -8.6378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0490 -8.7197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4514 -9.6846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7551 -8.3113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6402 -7.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0485 -8.0288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1812 -9.6145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3427 -8.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13 18 1 0
16 13 1 0
8 19 1 0
9 2 1 0
14 1 2 0
14 16 1 0
12 8 1 0
11 3 2 0
20 14 1 0
8 10 1 6
6 12 1 0
11 6 1 0
13 9 1 1
4 20 1 0
5 16 1 0
19 11 1 0
4 10 1 0
18 17 1 0
10 7 2 0
9 15 2 0
17 5 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.30 | Molecular Weight (Monoisotopic): 282.1328 | AlogP: -2.14 | #Rotatable Bonds: 4 |
Polar Surface Area: 121.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.28 | CX Basic pKa: ┄ | CX LogP: -3.07 | CX LogD: -3.07 |
Aromatic Rings: ┄ | Heavy Atoms: 20 | QED Weighted: 0.54 | Np Likeness Score: -1.06 |
References
1. (2010) TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme, |